Patents by Inventor Michael Aarons

Michael Aarons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASYMMETRIC PROCESSING METHOD FOR REDUCING BOW IN LAMINATE STRUCTURES
    Publication number: 20170182739
    Abstract: Disclosed herein are methods for making asymmetric laminate structures and methods for reducing bow in asymmetric laminate structures, the methods comprising differentially heating the laminate structures during lamination or differentially cooling the laminate structures after lamination. Also disclosed herein are methods for reducing bow in asymmetric laminate structures, the methods comprising subjecting at least one substrate in the laminate structure to asymmetric tempering or annealing prior to lamination. Further disclosed herein are laminate structures made according to such methods.
    Type: Application
    Filed: December 21, 2016
    Publication date: June 29, 2017
    Inventors: James Gregory Couillard, Michael Aaron McDonald, Paul George Rickerl
  • Wireless device enabled locking system
    Patent number: 9691201
    Abstract: An encrypted security system and associated methods for controlling physical access. The system includes a security server configured to receive a request for authentication from a mobile device, the request comprising information identifying the mobile device and a physical access control device. The security server forwards an encryption message comprising a plurality of unique identifiers to the physical access control device via the mobile device. The physical access control device is configured to authenticate the plurality of unique identifiers in the encryption message and operate an access control mechanism.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: June 27, 2017
    Assignee: DELPHIAN SYSTEMS, LLC
    Inventors: Gary L. Myers, Ashok Hirpara, John D. Veleris, Arkadiusz Zimny, Michael Aaron Cohen, Eugene Nakshin
  • 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,3-Thiazol-4-yl Amides
    Publication number: 20170151252
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: February 8, 2017
    Publication date: June 1, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • CONNECTOR FOR AN OPTICAL FIBER AND COMBINATIONS, KITS, AND METHODS OF USING THE SAME
    Publication number: 20170146749
    Abstract: A portable device for attaching a connector to an optical fiber, the optical fiber having an end, the device comprising means for receiving the optical fiber at the end of the optical fiber; and a connector station for autonomously attaching the connector to the optical fiber.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 25, 2017
    Inventors: Danny Willy August VERHEYDEN, David Donald ERDMAN, Michael GURRERI, Randall Bobby Paul, Jan WATTÉ, Robert Charles FLAIG, Alan Edward PLOTTS, Michael Aaron KADAR-KALLEN, Shelly Anne BUCHTER, Jan VANDENBROECK, Patrick BILLET, Stefano BERI, André Johannes Maria HILDERINK, Hernes JACOBS, Petrus Theodorus RUTGERS, Petrus Theodorus KRECHTING, Martijn Johannes WOLBERS, Walter MATTHEUS, Cristian-Radu RADULESCU, Paul VITS, Karel Johannes VAN ASSENBERGH, Pieter Cornelis Johan DE JAGER, Henk Jan Theodoor VAN DER POL
  • N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides
    Patent number: 9611264
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: April 4, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Romelia del Carmen Salomon Ferrer
  • N-[2-(2-Amino-6,6-Disubstituted-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-YL)-1,3-Thiazol-4-YL]Amides
    Publication number: 20170088558
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 30, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou
  • N-(2-(2-AMINO-6-SUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]OXAZIN-8a(8H)-YL)-THIAZOL-4-YL) AMIDES
    Publication number: 20170088556
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 30, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill
  • N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL] AMIDES
    Publication number: 20170088547
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 30, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Romelia del Carmen Salomon Ferrer
  • 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
    Patent number: 9605007
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: March 28, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
    Publication number: 20170057947
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g.
    Type: Application
    Filed: November 11, 2016
    Publication date: March 2, 2017
    Applicant: PFIZER INC.
    Inventors: MICHAEL AARON BRODNEY, JENNIFER ELIZABETH DAVOREN, AMY BETH DOUNAY, IVAN VIKTOROVICH EFREMOV, DAVID LAWRENCE FIRMAN GRAY, MICHAEL ERIC GREEN, JACLYN LOUISE HENDERSON, CHEWAH LEE, SCOT RICHARD MENTE, STEVEN VICTOR O'NEIL, BRUCE NELSEN ROGERS, LEI ZHANG
  • Mortise lock apparatus and electronic operating system
    Patent number: 9580931
    Abstract: The disclosure describes a locking system for a door with a mortise pocket. The locking system has a mortise case within the mortise pocket. The mortise case defines an alignment hole. The locking system also has a gear box with a worm gear that defines a notched passage that receives a lock knob shaft. A worm within the gear box is coupled to a motor that rotates the worm. The worm engages the worm gear such that the worm gear rotates when the worm rotates. A control board in the gear box is adapted to receive electronic signals and transmit them to the motor to cause the motor to rotate the worm. The gear box also has a worm gear hub that defines a keyed passage and a hub tab. The worm gear hub fits within the notched passage and the keyed passage receives the lock knob shaft. The worm gear also has two notches that the hub tab contacts individually when the gear hub rotates within the notched passage.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: February 28, 2017
    Assignee: Belwith Products, LLC
    Inventors: Gary L. Myers, Ashok Hirpara, Michael Aaron Cohen, John D. Veleris, Alyssa M. Nelson
  • ACTIVE SENSING SYSTEM AND METHOD OF SENSING WITH AN ACTIVE SENSOR SYSTEM
    Publication number: 20170052276
    Abstract: An active sensing system includes an agent and at least one sensor operatively associated with the agent. The at least one sensor includes one or more emitters configured and disposed to establish a sensing zone. A conflict identification module is configured and disposed to identify one or more sensor conflict regions, and an active sensor controller is operatively connected to the at least one sensor and the conflict identification module. The active sensor controller is configured and disposed to form an adjustment zone within the sensing zone to accommodate the one or more sensor conflict regions.
    Type: Application
    Filed: June 16, 2016
    Publication date: February 23, 2017
    Inventor: Michael Aaron Connor
  • EXPANDED BEAM CONNECTOR WITH DISCRETE ALIGNMENT ASSEMBLY
    Publication number: 20170052326
    Abstract: An alignment assembly for disposition in an insert for an expanded beam connector, said alignment assembly comprising: (a) at least one cylindrical sleeve having an inner first diameter, and an outer diameter configured to be received in said insert of said connector; (b) a lens disposed in said sleeve, and having a round periphery with a second diameter larger than said first diameter; and (c) a ferrule stub disposed at least partially in said sleeve, and having a round periphery with a third diameter essentially the same as the second diameter, said ferrule stub comprising a fiber stub optically coupled to said lens.
    Type: Application
    Filed: August 21, 2015
    Publication date: February 23, 2017
    Inventors: SOREN GRINDERSLEV, MICHAEL AARON KADAR-KALLEN
  • HETEROCYCLIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
    Publication number: 20170044174
    Abstract: The present invention provides, in part, compounds of Formula (I): and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.
    Type: Application
    Filed: April 14, 2015
    Publication date: February 16, 2017
    Applicant: PFIZER INC.
    Inventors: DAVID LAWRENCE FIRMAN GRAY, LEI ZHANG, MICHAEL AARON BRODNEY, JENNIFER ELIZABETH DAVOREN, IVAN VIKTOROVICH EFREMOV, MICHAEL ERIC GREEN, STEVEN VICTOR O'NEIL, BRUCE NELSEN ROGERS
  • Spatial and temporal verification of users and/or user devices
    Patent number: 9571485
    Abstract: Approaches for facilitating spatial and temporal verification of users and/or user devices are disclosed. In some implementations, a user device may be detected within a short wireless communication range. A wireless communication session with the user device may be initiated based on the detection. Information identifying a first integrity-based certificate may be received from the user device during the wireless communication session during a first time period. Information identifying a second integrity-based certificate associated with a second time period may be provided responsive to determining that the first integrity-based certificate is a valid integrity-based certificate associated with the first time period. The second integrity-based certificate may be configured to allow network access for the user device during the second time period.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: February 14, 2017
    Assignees: Michael Aaron Le, GXM Consulting LLC
    Inventors: Michael Aaron Le, James Yeager
  • 1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS
    Publication number: 20170029390
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, traumatic brain injury, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.
    Type: Application
    Filed: July 28, 2016
    Publication date: February 2, 2017
    Applicant: PFIZER INC.
    Inventors: CHRISTOPHER RYAN BUTLER, LAURA ANN MCALLISTER, ELIZABETH MARY BECK, MICHAEL AARON BRODNEY, ADAM MATTHEW GILBERT, CHRISTOPHER JOHN HELAL, DOUGLAS SCOTT JOHNSON, JUSTIN IAN MONTGOMERY, STEVEN VICTOR O'NEIL, BRUCE NELSEN ROGERS, PATRICK ROBERT VERHOEST, DAMIEN WEBB
  • CONTRACEPTIVE AND RELATED DEVICE
    Publication number: 20170020718
    Abstract: An intravaginal ring for the controlled release of at least one bioactive agent may further contain at least one of a non-bioabsorbable microparticulate ion-exchanging polymer, a fully bioabsorbable polymeric matrix, a biostable hydrophilic elastomeric polymeric matrix, a biostable amphiphilic elastomeric polymeric matrix, a biostable elastomeric polymeric matrix containing an inorganic microparticulate, and a biostable elastomeric porous polymeric matrix, each to aid in the release and/or modulate the release of the bioactive agent.
    Type: Application
    Filed: April 1, 2015
    Publication date: January 26, 2017
    Applicant: POLY-MED, INC.
    Inventors: Kenneth David Gray, Jr., Michael Aaron Vaughn, Georgios Theofanis Hilas
  • Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
    Patent number: 9550795
    Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: January 24, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Christopher John Helal, Brian Thomas O'Neill
  • 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,3-Thiazol-4-yl Amides
    Publication number: 20170008911
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: July 20, 2016
    Publication date: January 12, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Tablet computer
    Patent number: D791121
    Type: Grant
    Filed: December 26, 2015
    Date of Patent: July 4, 2017
    Assignee: Intel Corporation
    Inventors: David M. Collins, Douglas Satzger, Michael Aaron Hyde